A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS)
Phase of Trial: Phase I/II
Latest Information Update: 11 Apr 2019
Price : $35 *
At a glance
- Drugs Triheptanoin (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- Acronyms PALS
- 08 Apr 2019 Status changed from active, no longer recruiting to completed.
- 15 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 31 Aug 2018 Biomarkers information updated